Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? (Q44791042)
Jump to navigation
Jump to search
scientific article published in December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? |
scientific article published in December 2014 |
Statements
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? (English)
Dennis M Black
Steven R Cummings
Steven Boonen
Felicia Cosman
1 December 2014